Literature DB >> 26876313

Cannabis-induced psychosis associated with high potency "wax dabs".

Joseph M Pierre1, Michael Gandal2, Maya Son3.   

Abstract

With mounting evidence that the risk of cannabis-induced psychosis may be related to both dose and potency of tetrahydrocannbinol (THC), increasing reports of psychosis associated with cannabinoids containing greater amounts of THC are anticipated. We report two cases of emergent psychosis after using a concentrated THC extract known as cannabis "wax," "oil," or "dabs" raising serious concerns about its psychotic liability. Although "dabbing" with cannabis wax is becoming increasingly popular in the US for both recreational and "medicinal" intentions, our cases raise serious concerns about its psychotic liability and highlight the importance of understanding this risk by physicians recommending cannabinoids for purported medicinal purposes. Published by Elsevier B.V.

Entities:  

Keywords:  Cannabis; Cannabis oil; Cannabis wax; Cannabis-induced psychosis, catatonia; Marijuana; Tetrahydrocannabinol

Mesh:

Substances:

Year:  2016        PMID: 26876313     DOI: 10.1016/j.schres.2016.01.056

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  27 in total

1.  Modes of Marijuana Consumption Among Colorado High School Students Before and After the Initiation of Retail Marijuana Sales for Adults.

Authors:  Kayla N Tormohlen; Ashley Brooks-Russell; Ming Ma; Kristin E Schneider; Arnold H Levinson; Renee M Johnson
Journal:  J Stud Alcohol Drugs       Date:  2019-01       Impact factor: 2.582

Review 2.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Authors:  Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-06-23       Impact factor: 9.308

3.  Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.

Authors:  Benedikt Fischer; Cayley Russell; Jürgen Rehm; Pamela Leece
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

Review 4.  Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int Rev Psychiatry       Date:  2018-05-29

5.  Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control.

Authors:  Daniel G Orenstein; Stanton A Glantz
Journal:  J Psychoactive Drugs       Date:  2018-02-13

6.  Marijuana advertising exposure among current marijuana users in the U.S.

Authors:  Melissa J Krauss; Shaina J Sowles; Auriann Sehi; Edward L Spitznagel; Carla J Berg; Laura J Bierut; Patricia A Cavazos-Rehg
Journal:  Drug Alcohol Depend       Date:  2017-03-29       Impact factor: 4.492

7.  Frequently asked questions about dabbing concentrates in online cannabis community discussion forums.

Authors:  Meredith C Meacham; Shim Roh; Jamie Suki Chang; Danielle E Ramo
Journal:  Int J Drug Policy       Date:  2019-08-07

8.  A Twitter-based survey on marijuana concentrate use.

Authors:  Raminta Daniulaityte; Mussa Y Zatreh; Francois R Lamy; Ramzi W Nahhas; Silvia S Martins; Amit Sheth; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2018-04-11       Impact factor: 4.492

Review 9.  A review of the anesthetic implications of marijuana use.

Authors:  John C Alexander; Girish P Joshi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-05-21

10.  Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship?

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int J Drug Policy       Date:  2017-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.